RadarGet started
Startups

Innovafeed Secures, 51 Million to Scale Insect-Based Nutrition

Innovafeed Secures, 51 Million to Scale Insect-Based Nutrition
Tom Fisk · pexels

Paris-based biotech firm Innovafeed has secured, 51 million in new funding to accelerate the production of sustainable insect-based ingredients. This capital injection from major institutional backers signals a maturing market for alternative protein sources in global agriculture and pet food supply chains. The funding round was primarily supported by existing financial partners, including Creadev, QIA, Temasek, FFC, ABC Impact, and ADM. This move marks a significant development phase for the startup as it transitions from initial proof-of-concept to large-scale industrial deployment. By focusing on insect-based protein for animal nutrition and agricultural applications, Innovafeed is positioning itself within the broader shift toward circular economy models in food production. The involvement of ADM, a global leader in agricultural processing and nutrition, suggests that the integration of insect-derived ingredients into mainstream industrial supply chains is gaining strategic momentum. For investors and market analysts, the continued commitment from major sovereign wealth funds and private equity firms like Temasek and Creadev indicates a long-term confidence in the scalability of biotech-driven feed solutions. This capital will likely be deployed to optimize production efficiency and expand the company's footprint in the competitive alternative protein landscape. As traditional feed markets face pressure from sustainability mandates and supply chain volatility, the ability of firms like Innovafeed to secure substantial non-dilutive and equity-based funding highlights a growing appetite for industrial-scale biotech. Market participants should monitor how this scaling phase impacts the pricing of traditional animal feed commodities and whether further partnerships with global agribusiness conglomerates follow this financing round. While the insect-protein sector remains in a high-growth, capital-intensive stage, the successful mobilization of, 51 million in the current macroeconomic climate underscores the resilience of companies that solve critical resource-efficiency problems. The next 12 months will be crucial for the firm as it attempts to demonstrate that its technical processes can achieve the cost-parity required to compete with conventional soy and fishmeal alternatives on a global scale. Analysts should watch for potential downstream supply agreements or capacity expansion announcements that could further validate the commercial viability of this niche but rapidly evolving agricultural segment.